Insomnia Pharmacotherapy

Efficacy and Safety of 6-Month Nightly Ramelteon Administration in Adults with Chronic Primary Insomnia

(2017) Geert Mayer et al.   SLEEP

The Orexin Antagonist SB-649868 Promotes and Maintains Sleep in Men with Primary Insomnia

(2012) Paolo Bettica et al.   SLEEP

Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study

(2011) Timothy A Roehrs et al.   JOURNAL OF PSYCHOPHARMACOLOGY

T-D-001 ABSENCE OF TOLERANCE, DEPENDENCE POTENTIAL, AND REBOUND DURING PRN TREATMENT OF MIDDLE-OF-THE-NIGHT AWAKENINGWITH ZOLPIDEM TARTRATE SUBLINGUAL TABLET 3.5MG

(2011) Thomas Roth et al.   SLEEP MEDICINE

Does Effective Management of Sleep Disorders Improve Pain Symptoms?

(2010) Timothy A. Roehrs   DRUGS

Improved Insomnia Symptoms and Sleep-Related Next-Day Functioning in Patients With Comorbid Major Depressive Disorder and Insomnia Following Concomitant Zolpidem Extended-Release 12.5 mg and Escitalopram Treatment

(2010) Maurizio Fava et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Post Hoc Analysis of the Effect of Nightly Administration of Eszopiclone and a Selective Serotonin Reuptake Inhibitor in Patients With Insomnia and Anxious Depression

(2010) Maurizio Fava et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Elderly Patients With Primary Insomnia

(2009) Martin Scharf et al.   JOURNAL OF CLINICAL PSYCHIATRY

Zolpidem Extended-Release Improves Sleep and Next-Day Symptoms in Comorbid Insomnia and Generalized Anxiety Disorder

(2009) Maurizio Fava et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Eszopiclone Coadministered With Escitalopram in Patients With Insomnia and Comorbid Generalized Anxiety Disorder

(2008) Mark Pollack et al.   ARCHIVES OF GENERAL PSYCHIATRY